Nijmegen is the oldest city in the Netherlands, but with a young and ambitious spirit at Radboudumc Investment Day.
The day was opened with flair by mayor Bruls and set in motion by Rinke Zonneveld (CEO of InvestNL), who skipped the slides and went straight for dialogue. I always enjoy his talks — never afraid to challenge the room. This time he was critical about the Netherlands’ open innovation model and the growing tangle of Dutch and EU regulations that slow medical innovation.
His message was clear: we need to rebuild our own capacity, invest consistently in key sectors, and stay open without being naive.
I was invited by Martijn Sijbers, and warmly hosted by Marion Schouten and Bart Heuts, who chaired the session in which I presented our mission, vision, and strategy. It’s been a great opportunity to exchange ideas and engage with potential partners.
Why flow cytometry gating is a machine learning problem worth solving
Manual gating introduces variability, requires second-person review, and becomes a bottleneck as data volumes grow. This blog explains why gating is fundamentally a machine learning problem and how it can be standardized and automated in practice.
